⏳
Showing Q1 2025 data
Cutter Capital Management, LP's Q4 2025 filing not yet available. Expected by Feb 14, 2026.
Cutter Capital Management, LP
•CIK: 1983313•Filing: Q1 2025
**Cutter Capital Management, LP** manages $230M across a concentrated portfolio of 21 positions. The fund exhibits a pronounced focus on the biotechnology and pharmaceutical sectors, evidenced by its top holdings. Key allocations include BMY at $18.0M, followed by AMGN ($15.6M), BIIB ($15.5M), and LLY ($14.9M). This concentration suggests a deep, conviction-driven thesis within innovative healthcare assets.
Total AUM
$229.6M
QoQ Performance
-5.9%
Positions
21
Top 10 Concentration
62.8%
Latest Filing
Q1 2025
Top Holdings Allocation
BMY
AMGN
BIIB
LLY
IM8N
RARE
BBIO
PRGO
BMY7.8%
AMGN6.8%
BIIB6.8%
LLY6.5%
IM8N6.2%
RARE6.0%
BBIO5.9%
PRGO5.9%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other78.9%
Healthcare21.1%
🚪 Exited Positionssold since Q4 2024
+5 more exited positions
Changes from Q4 2024
NEW10 new positions
↑5 increased
↓6 decreased
Historical Filings
Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023